Andre Goy, MD, MS
Advertisement
Articles by Andre Goy, MD, MS
Advertisement
Latest Updated Articles
Dr. Goy on the Evolution of Treatment Selection in MCLPublished: May 12th 2020 | Updated:
Dr. Goy on Research Efforts With BTK Inhibitors in MCLPublished: May 11th 2020 | Updated:
Dr Goy on Outcomes From An Expanded Access Study of Brexu-Cel in Relapsed/Refractory MCLPublished: December 10th 2023 | Updated:
Dr. Goy on Changing Treatment Landscape of Mantle Cell LymphomaPublished: December 20th 2016 | Updated:
Dr. Goy on Rituximab Maintenance Therapy for Patients With MCLPublished: December 21st 2016 | Updated:
Dr. Goy on Bortezomib in MCL TreatmentPublished: December 30th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5